FDA Approves IRWD's Gout Drug, It's A Thumbs Up For ALXN In EU, CRME Crushed

Today's Daily Dose brings you news about European approval of Alexion's Soliris for an additional indication; Alkermes' New Drug Application for a major depressive disorder drug; Astellas' MORPHO trial progress; Axovant's move to NASDAQ from the Big Board; Cardiome's disappointing update related to its antiarrhythmic drug and FDA approval of Ironwood's gout drug.

from RTT - Biotech http://ift.tt/2wzeVJn
via IFTTT